US Stock Movement | Regencell Bioscience rises over 18%, total market value exceeds 4.8 billion USD
I'm PortAI, I can summarize articles.
On Wednesday, Regencell Bioscience's stock price soared, rising over 18% as of the time of publication, reaching USD 370.43, with a market capitalization exceeding USD 4.8 billion. Regencell Bioscience is an early-stage biotech company focused on traditional Chinese medicine treatments for neurocognitive disorders and degenerative diseases. The company was established on October 30, 2014, and is registered in the Cayman Islands, primarily operating through its subsidiary in Hong Kong
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments